RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      SCOPUS KCI등재

      호산구증가 혈관림프구증식 15예의 임상 및 병리조직학적 연구 = A Clinicopathologic Study of 15 Cases of Angiolymphoid Hyperplasia with Eosinophilia호산구증가 혈관림프구증식 15예의 임상 및 병리조직학적 연구

      한글로보기

      https://www.riss.kr/link?id=A75121734

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      Background: Angiolymphoid hyperplasia with eosinophilia (ALHE) is an uncommon distinctive vascular lesion characterized by proliferation of endothelial cells. Because of its rarity, the clinical and pathological aspects of ALHE have not been fully studied in Korea. Objective: The purpose of our investigation was to describe the clinical and pathological characteristics of ALHE. Methods: We reviewed the medical records, clinical photographs and histological slides of 15 patients who were diagnosed as ALHE at Severance hospital. Results: Of the 15 patients, 60% were men and 40% women. The average onset age of men was 53.7 years, women 33.2 years. Overall average onset age was 45.5 years. The scalp was the most frequently involved site in ALHE. Pruritus was the most common symptom. Two of four patients demonstrated peripheral blood eosinophilia and one patient showed elevation of serum IgE. The essential microscopic features of the fifteen lesions of ALHE were epithelioid proliferation of endothelial cells and perivascular inflammatory infiltration with eosinophils and lymphocytes. Four patients underwent surgery as their sole treatment modality and there were no recurrences. Other treatment modalities were topical steroid, intralesional injection of triamcinolone, systemic steroid, and 5% imiquimod cream. Conclusion: The clinical and pathological features of patients in this survey differ from previous studies in the age of onset, gender distribution, and anatomical distribution. Men were more affected (60%) than woman (40%), and the average age of onset was 45.5 years. The scalp and extremities were the most frequently involved sites. Surgery was the treatment of choice in ALHE. However, the clinical findings of ALHE need to be further evaluated in larger groups of patients. (Korean J Dermatol 2008;46(7):881~888)
      번역하기

      Background: Angiolymphoid hyperplasia with eosinophilia (ALHE) is an uncommon distinctive vascular lesion characterized by proliferation of endothelial cells. Because of its rarity, the clinical and pathological aspects of ALHE have not been fully stu...

      Background: Angiolymphoid hyperplasia with eosinophilia (ALHE) is an uncommon distinctive vascular lesion characterized by proliferation of endothelial cells. Because of its rarity, the clinical and pathological aspects of ALHE have not been fully studied in Korea. Objective: The purpose of our investigation was to describe the clinical and pathological characteristics of ALHE. Methods: We reviewed the medical records, clinical photographs and histological slides of 15 patients who were diagnosed as ALHE at Severance hospital. Results: Of the 15 patients, 60% were men and 40% women. The average onset age of men was 53.7 years, women 33.2 years. Overall average onset age was 45.5 years. The scalp was the most frequently involved site in ALHE. Pruritus was the most common symptom. Two of four patients demonstrated peripheral blood eosinophilia and one patient showed elevation of serum IgE. The essential microscopic features of the fifteen lesions of ALHE were epithelioid proliferation of endothelial cells and perivascular inflammatory infiltration with eosinophils and lymphocytes. Four patients underwent surgery as their sole treatment modality and there were no recurrences. Other treatment modalities were topical steroid, intralesional injection of triamcinolone, systemic steroid, and 5% imiquimod cream. Conclusion: The clinical and pathological features of patients in this survey differ from previous studies in the age of onset, gender distribution, and anatomical distribution. Men were more affected (60%) than woman (40%), and the average age of onset was 45.5 years. The scalp and extremities were the most frequently involved sites. Surgery was the treatment of choice in ALHE. However, the clinical findings of ALHE need to be further evaluated in larger groups of patients. (Korean J Dermatol 2008;46(7):881~888)

      더보기

      참고문헌 (Reference)

      1 Sidbury R, "Topically applied imiquimod inhibits vasculartumor growth in vivo" 121 : 1205-1209, 2003

      2 Rosai J, "The histiocytoid hemangiomas. Aunifying concept embracing several previously described entities of skin, soft tissue, large vessels, bone, and heart" 10 : 707-730, 1979

      3 Wells GC, "Subcutaneous angiolymphoid hyperplasia with eosinophilia" 81 : 1-14, 1969

      4 Reed RJ, "Subcutaneous angioblastic lymphoid hyperplasia with eosinophilia (Kimura's disease)" 29 : 489-497, 1972

      5 Enzinger FM, "Soft tissue tumors. 1st ed" The C. V. Mosby Co. 371-397, 1983

      6 Fernandez LA, "Renin in angiolymphoid hyperplasiawith eosinophilia. Its possible effect on vascular proliferation" 110 : 1131-1135, 1986

      7 Ahn KW, "Pathologic study of Kimura's disease" 25 : 501-510, 1984

      8 Fetsch JF, "Observations concerning the pathogenesis of epithelioid hemangioma (angiolymphoid hyperplasia)" 4 : 449-455, 1991

      9 Helander SD, "Kimura's diseaseand angiolymphoid hyperplasia with eosinophilia: new observations from immunohistochemical studies of lymphocyte markers, endothelial antigens, and granulocyte proteins" 22 : 319-326, 1995

      10 Googe PB, "Kimura's disease and angiolymphoid hyperplasia with eosinophilia: two distinct histopathological entities" 14 : 263-271, 1987

      1 Sidbury R, "Topically applied imiquimod inhibits vasculartumor growth in vivo" 121 : 1205-1209, 2003

      2 Rosai J, "The histiocytoid hemangiomas. Aunifying concept embracing several previously described entities of skin, soft tissue, large vessels, bone, and heart" 10 : 707-730, 1979

      3 Wells GC, "Subcutaneous angiolymphoid hyperplasia with eosinophilia" 81 : 1-14, 1969

      4 Reed RJ, "Subcutaneous angioblastic lymphoid hyperplasia with eosinophilia (Kimura's disease)" 29 : 489-497, 1972

      5 Enzinger FM, "Soft tissue tumors. 1st ed" The C. V. Mosby Co. 371-397, 1983

      6 Fernandez LA, "Renin in angiolymphoid hyperplasiawith eosinophilia. Its possible effect on vascular proliferation" 110 : 1131-1135, 1986

      7 Ahn KW, "Pathologic study of Kimura's disease" 25 : 501-510, 1984

      8 Fetsch JF, "Observations concerning the pathogenesis of epithelioid hemangioma (angiolymphoid hyperplasia)" 4 : 449-455, 1991

      9 Helander SD, "Kimura's diseaseand angiolymphoid hyperplasia with eosinophilia: new observations from immunohistochemical studies of lymphocyte markers, endothelial antigens, and granulocyte proteins" 22 : 319-326, 1995

      10 Googe PB, "Kimura's disease and angiolymphoid hyperplasia with eosinophilia: two distinct histopathological entities" 14 : 263-271, 1987

      11 Chun SI, "Kimura's disease and angiolymphoid hyperplasia with eosinophilia: clinical and histopathologic differences" 27 : 954-958, 1992

      12 Rosai J, "Histiocytoid hemangioma. A proposal of a new entity which embraces previously described diseases of heart, blood vessels, skin, bone and other sites" 67 : 190-191, 1980

      13 Jang KA, "Histiocytoid hemangioma (angiolymphoid hyperplasia with eosinophilia): effective treatment with dapsone" 35 : 350-353, 1997

      14 Akdeniz N, "GelincikI. Intralesional bleomycin for angiolymphoid hyperplasia" 143 : 841-844, 2007

      15 Moy RL, "Estrogen receptors and the response to sex hormones in angiolymphoid hyperplasia with eosinophilia" 128 : 825-828, 1992

      16 Urabe A, "Epithelioid hemangiomaversus Kimura's disease. A comparative clinicopathologicstudy" 11 : 758-766, 1987

      17 Kandil E, "Dermal angiolymphoid hyperplasia with eosinophilia versus pseudopyogenic granuloma" 83 : 405-408, 1970

      18 Burg G, "Collision dermatosis: angiolymphoid hyperplasiawith eosinophilia developing within a congenital port winenevus" 187 : 293-295, 1993

      19 Sanchez-Carpintero I, "Clinicaland histopathologic observations of the action of imiquimodin an epithelioid hemangioendothelioma and Paget's mammarydisease" 55 : 75-79, 2006

      20 Grimwood R, "Angiolymphoidhyperplasia with eosinophilia" 115 : 205-207, 1979

      21 Gencoglan G, "Angiolymphoid hyperplasiawith eosinophilia successfully treated with imiquimod.A case report" 215 : 233-235, 2007

      22 Redondo P, "Angiolymphoid hyperplasiawith eosinophilia successfully treated with imiquimod" 151 : 1110-1111, 2004

      23 Mehregan AH, "Angiolymphoid hyperplasia witheosinophilia" 103 : 50-57, 1971

      24 Henry PG, "Angiolymphoid hyperplasia witheosinophilia" 114 : 1168-1172, 1978

      25 Person JR, "Angiolymphoid hyperplasia with eosinophiliamay respond to pentoxifylline" 31 : 117-118, 1994

      26 Nomura K, "Angiolymphoid hyperplasia with eosinophilia: successfultreatment with indomethacin farnesil" 134 : 189-190, 1996

      27 Olsen TG, "Angiolymphoid hyperplasia with eosinophilia. A clinicopathologic study of 116 patients" 12 : 781-796, 1985

      28 Jang KA, "Angiolymphoid hyperplasia with eosinophilia and Kimura's disease: a clinico-pathologic study in Korea" 39 : 309-317, 2001

      29 Lee JH, "A comparative clinicopathologic study between Kimura's disease and epithelioid hemangioma" 36 : 405-412, 1993

      30 Ahn HJ, "A clinicopathological study of Kimura's disease and epithelioid hemangioma" 31 : 205-211, 1990

      31 Mok HS, "A case of angiolymphoidhyperplasis with eosinophilia" 23 : 526-530, 985

      32 Juhn BJ, "A case of angiolymphoid hyperplasia with eosinophilla associated with arterlovenous malformations" 37 : 78-81, 1999

      33 Hur SG, "A case of angiolymphoid hyperplasia with eosinophilia and its treatment with carbon dioxide laser" 29 : 130-135, 1991

      34 Shin SS, "A case of angiolymphoid hyperplasia with eosinophilia" 38 : 836-837, 2000

      35 Kwark EH, "A case of angiolymphoid hyperplasia with eosinophilia" 26 : 125-129, 1988

      36 Choi SW, "A case of Kimura'sdisease" 23 : 248-252, 1985

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-06-29 학술지명변경 외국어명 : 미등록 -> Korean Journal of Dermatology KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2003-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2002-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2000-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.11 0.11 0.13
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.13 0.14 0.254 0.01
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼